Stromal‐Derived IL‐8 Promotes M2 Macrophage Polarization via the RhoA/MRTF‐A/SRF Transcriptional Axis to Impair CD8 + T Cell Cytotoxicity in Lung Cancer
Advanced Science · 2026-09 · 13 (49)
DOI: 10.1002/advs.202508001 ↗Kurz gefasst
Fachartikel in der Zeitschrift Advanced Science, online erschienen am 16.07.2026. Verfasst von Xuyu Gu und 7 weiteren Autor:innen. Beteiligte Einrichtung: Department of Oncology, School of Medicine, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University, Shangh…. Hauptthemen laut MEDLINE: Lung Neoplasms, Interleukin-8, CD8-Positive T-Lymphocytes, Macrophages. Die Arbeit wurde bisher 1-mal zitiert (Crossref) und nennt 59 Literaturangaben. Der Volltext ist frei zugänglich (Open Access, CC BY 4.0). Gefördert von: National Natural Science Foundation of China.
Abstract (Originalsprache)
Background
Building upon our previous finding that tumor‐derived lactate activates DESMIN + cancer‐associated fibroblasts (CAFs) to secrete interleukin‐8 (IL‐8), this study investigates the downstream IL‐8/C‐X‐C motif chemokine receptor 2 (CXCR2) axis in CAF‐mediated macrophage polarization and lung cancer (LC) progression.
Methods
Orthotopic and subcutaneous tumor models were established in immunocompetent and immunodeficient mice using LC, CAFs, or murine tumor organoids (MTO). Global and myeloid‐specific Cxcr2 knockout models, in vitro co‐cultures (macrophages, CD8 + T cells, and tumor cells), and patient‐derived organoid (PDO) systems were employed.
Results
DESMIN + CAFs were the predominant source of IL‐8 and promoted tumorigenesis and M2‐like macrophage accumulation via the IL‐8/CXCR2 axis. Genetic deletion of Cxcr2 , myeloid‐specific knockout, or pharmacological blockade reduced M2‐like macrophage polarization through the PI3K/AKT/RhoA/MRTF‐A/SRF pathway, restored CD8 + T cell effector function, and suppressed tumor progression. CXCR2 blockade also synergized with chemotherapy and anti‐PD‐L1 immunotherapy in murine models. In human PDO co‐cultures with matched DESMIN + CAFs and autologous CD8 + T cells, CXCR2 inhibition attenuated M2‐like polarization and enhanced T cell‐mediated killing of tumor organoids.
Conclusion
DESMIN + CAFs drive an immunosuppressive tumor microenvironment in LC through IL‐8/CXCR2 signaling and downstream MRTF‐A activation. Targeting this axis represents a promising strategy to overcome treatment resistance in LC.
Schlagwörter
MeSH-Schlagwörter (MEDLINE)
Stichwörter der Autor:innen
Substanzen
Autor:innen und Institutionen
- Department of Oncology, School of Medicine, Shanghai Pulmonary Hospital, Tongji University Medical School Cancer Institute, Tongji University, Shanghai, China.
- Department of Biotherapy, Cancer Center, West China Hospital, Sichuan University, Chengdu, China.
- Department of Pathology and Laboratory of Pathology, State Key Laboratory of Biotherapy, West China School of Medicine, West China Hospital, Sichuan University, Chengdu, China.
- Department of Thoracic Surgery, Shanghai Pulmonary Hospital, School of Medicine, Tongji University, Shanghai, China.
ORCID-Profile: Wentian Zhang
Förderung
- National Natural Science Foundation of China
Zitieren
APA
Gu, X., Fang, Q., Yu, J., Yu, T., Shi, H., Jin, K., Jiang, L., & Zhang, W. (2026). Stromal‐Derived IL‐8 Promotes M2 Macrophage Polarization via the RhoA/MRTF‐A/SRF Transcriptional Axis to Impair CD8 + T Cell Cytotoxicity in Lung Cancer. Advanced Science, 13(49). https://doi.org/10.1002/advs.202508001
Vancouver
Gu X, Fang Q, Yu J, Yu T, Shi H, Jin K, et al. Stromal‐Derived IL‐8 Promotes M2 Macrophage Polarization via the RhoA/MRTF‐A/SRF Transcriptional Axis to Impair CD8 + T Cell Cytotoxicity in Lung Cancer. Advanced Science. 2026;13(49). doi:10.1002/advs.202508001
BibTeX
@article{Gu2026,
author = {Gu, Xuyu and Fang, Qiyu and Yu, Jia and Yu, Ting and Shi, Huashan and Jin, Kaiqi and Jiang, Lei and Zhang, Wentian},
title = {Stromal‐Derived IL‐8 Promotes M2 Macrophage Polarization via the RhoA/MRTF‐A/SRF Transcriptional Axis to Impair CD8 + T Cell Cytotoxicity in Lung Cancer},
journal = {Advanced Science},
year = {2026},
volume = {13},
number = {49},
doi = {10.1002/advs.202508001}
}
EUVIMED